Type II topoisomerase
Enzyme that alters the supercoiling of double-stranded DNA
Type II topoisomerase is an enzyme that plays a crucial role in the manipulation of the topology of DNA. It is responsible for managing the supercoiling and entanglement of double-stranded DNA molecules during various cellular processes such as DNA replication, transcription, and chromosome segregation.
Function
Type II topoisomerases are essential for the maintenance of DNA topology. They function by creating transient double-strand breaks in the DNA molecule, allowing the passage of another segment of the double helix through the break, and then resealing the break. This mechanism is vital for resolving DNA supercoiling and catenation that occur during DNA replication and other cellular processes.
Mechanism
The enzyme operates by a "cut-and-pass" mechanism. It first binds to a segment of DNA, introduces a double-strand break, and then passes another segment of the DNA through this break before resealing it. This action requires the hydrolysis of ATP, which provides the necessary energy for the conformational changes in the enzyme.
Types
There are two main types of type II topoisomerases: DNA gyrase and topoisomerase IV. DNA gyrase is unique to bacteria and is responsible for introducing negative supercoils into DNA, which is crucial for DNA replication and transcription. Topoisomerase IV, also found in bacteria, primarily functions in the decatenation of replicated chromosomes.
Structure
Type II topoisomerases are typically composed of multiple subunits. The structure of these enzymes is complex, allowing them to perform their function of cutting and rejoining DNA strands. The enzyme's active site is responsible for the cleavage and re-ligation of DNA.
Inhibitors
Type II topoisomerases are targets for several antibiotics and anticancer drugs. Inhibitors such as quinolones and etoposide interfere with the enzyme's ability to manage DNA topology, leading to cell death. These inhibitors are used in the treatment of bacterial infections and cancer.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD